Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Home
  • Home
Article
  • Cited by 28

  • Access

Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: A new approach to an old problem

  • Michael Poyurovsky (a1) and Abraham Weizman (a1)
  • View HTML

      • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: A new approach to an old problem
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: A new approach to an old problem
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: A new approach to an old problem
      Available formats
      ×

Abstract

  • An abstract is not available for this content so a preview has been provided below. To view the full text please use the links above to select your preferred format.

Copyright

COPYRIGHT: © Royal College of Psychiatrists, 2001 

Corresponding author

A. Weizman, Research Unit, Geha Psychiatric Hospital, PO Box 102, PetahTiqva 49100, Israel. Tel: +972 3 9258290; Fax: +972 3 9241041; e-mail: weizmana@post.tau.ac.il

References

Hide All
Adler, L. A., Angrist, B., Retter, S., et al (1989) Neuroleptic-induced akathisia: a review. Psychopharmacology, 97, 1–11.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington, DC: APA.
Barnes, T. R. E. (1989) A rating scale for drug-induced akathisia. British Journal of Psychiatry, 154, 672–676.
Barnes, T. R. E. & McPhillips, M. A. (1999) Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics. British Journal of Psychiatry, 174 (suppl. 38), 34–43.
D'Mello, D. A., McNeil, J. A. & Harris, W. (1989) Buspirone suppression of neuroleptic-induced akathisia: multiple case reports (letter). Journal of Clinical Psychopharmacology, 9, 151–152.
Fischel, T., Hermesh, H., Alzenberg, D., et al (2001) Cyproheptadine vs. propranolol for the treatment of acute neuroleptic-induced akathisia: A comparative double-blind study. Journal of Clinical Psychopharmacology, in press.
Fleischhacker, W. W., Roth, S. D. & Kane, J. M. (1990) The pharmacologic treatment of neuroleptic-induced akathisia. Journal of Clinical Psychopharmacology, 10, 12–21.
Kapur, S. & Remington, G. (1996) Serotonin – dopamine interaction and its relevance to schizophrenia. American Journal of Psychiatry, 153, 466–476.
Lane, R. M. (1998) SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. Journal of Psychopharmacology, 12, 192–214.
Leysen, J. E., Gommeren, W. & Shotte, A. (1996) Serotonin receptor subtypes: possible roles and applications in antipsychotic drug action. In Serotonin in Antipsychotic Treatment. Mechanisms and Clinical Practice (eds Kane, J. M., Moller, H.-J. & Awouters, F.), pp. 51–75. New York: Marcel Dekker.
Meltzer, H. Y. (1999) The role of serotonin in antipsychotic drug action. Neuropsychopharmacology, 21 (suppl. 2), 106S–115S.
Miller, G. H., Fleischhacker, W. W., Ehrman, H., et al (1990) Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist ritanserin. Psychopharmacology Bulletin, 26, 373–376.
Miller, C. H., Hummer, M., Pycha, R., et al (1992) The effect of ritanserin on treatment-resistant neuroleptic-induced akathisia: case reports. Progress in Neuropsychopharmacology and Biological Psychiatry, 16, 247–251.
Poyurovsky, M. & Weizman, A. (1997) Serotonergic agents in the treatment of acute neuroleptic-induced akathisia: open-label study of buspirone and mianserin. International Clinical Psychopharmacology, 12, 263–268.
Poyurovsky, M. & Weizman, A. (1999) Lack of efficacy of the 5-HT3 receptor antagonist granisetron in the treatment of acute neuroleptic-induced akathisia. International Clinical Psychopharmacology, 14, 357–360.
Poyurovsky, M. & Weizman, A. (2001) Low dose mirtazapine ameliorates acute neuroleptic-induced akathisia (letter). American Journal of Psychiatry, in press.
Poyurovsky, M., Fuchs, C. & Weizman, A. (1998) Low-dose mianserin in the treatment of acute neuroleptic-induced akathisia. Journal of Clinical Psychopharmacology, 18, 253–254.
Poyurovsky, M., Shardorodsky, M., Fuchs, C., et al (1999) Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin. Double-blind, placebo-controlled study. British Journal of Psychiatry, 174, 238–242.
Richelson, E. (1996) Preclinical pharmacology of neuroleptics; focus on new generation compounds. Journal of Clinical Psychiatry, 57 (suppl. 11), 4–10.
Seeman, P. & Tallerico, T. (1998) Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors yet occupy high levels of these receptors. Molecular Psychiatry, 3, 123–134.
Weiss, D., Aizenberg, D., Hermesh, H., et al (1995) Cyproheptadine treatment in neuroleptic-induced akathisia. British Journal of Psychiatry, 167, 483–486.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

  • Cited by 28

  • Access

Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: A new approach to an old problem

  • Michael Poyurovsky (a1) and Abraham Weizman (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *